[10-Q] Ryan Specialty Holdings, Inc. Quarterly Earnings Report
RYAN Q2-25 (10-Q) highlights:
- Total revenue rose 23% YoY to $855.2 M, driven by Wholesale Brokerage +7%, Binding Authority +17% and an 73% surge in Underwriting Management.
- Operating income grew 16% to $191.1 M; operating margin slipped 120 bp to 22.3% as compensation and amortization outpaced top-line growth.
- Net income attributable to RYAN increased 11% to $52.0 M; diluted EPS up to $0.38 (vs $0.37).
- Six-month view: revenue +24% to $1.55 B, but EPS fell 63% to $0.18 on sharply higher amortization (+130%) and interest expense (+86%).
- Interest expense climbed to $58.3 M in the quarter, reflecting higher borrowings; long-term debt now $3.41 B (+6% YTD).
- Cash & equivalents fell to $172.6 M (-68% YTD) after $565 M cash spent on three acquisitions: Velocity Risk Underwriters, USQRisk Holdings and 360° Underwriting. Goodwill rose to $3.09 B.
- Operating cash flow improved 37% to $210.8 M; however free cash flow was negative due to acquisition spend.
- Shares outstanding: 128.0 M Class A, 135.7 M Class B as of 7/28/25.
Key takeaways: Strong organic and acquisitive growth continues, but leverage, amortization charges and TRA obligations are weighing on net earnings and liquidity.
RYAN Q2-25 (10-Q) punti salienti:
- I ricavi totali sono aumentati del 23% su base annua, raggiungendo 855,2 M$, trainati da Wholesale Brokerage +7%, Binding Authority +17% e un incremento del 73% in Underwriting Management.
- L'utile operativo è cresciuto del 16% a 191,1 M$; il margine operativo è sceso di 120 punti base al 22,3% a causa di compensi e ammortamenti superiori alla crescita dei ricavi.
- L'utile netto attribuibile a RYAN è aumentato dell'11% a 52,0 M$; l'EPS diluito è salito a 0,38$ (da 0,37$).
- Vista a sei mesi: ricavi +24% a 1,55 Mld$, ma EPS in calo del 63% a 0,18$ per effetto di ammortamenti (+130%) e oneri finanziari (+86%) significativamente più elevati.
- Le spese per interessi sono salite a 58,3 M$ nel trimestre, riflettendo maggiori indebitamenti; il debito a lungo termine è ora di 3,41 Mld$ (+6% da inizio anno).
- Liquidità e equivalenti sono scesi a 172,6 M$ (-68% da inizio anno) dopo una spesa in contanti di 565 M$ per tre acquisizioni: Velocity Risk Underwriters, USQRisk Holdings e 360° Underwriting. L'avviamento è salito a 3,09 Mld$.
- Il flusso di cassa operativo è migliorato del 37% a 210,8 M$; tuttavia il flusso di cassa libero è negativo a causa delle spese per acquisizioni.
- Azioni in circolazione: 128,0 M di Classe A, 135,7 M di Classe B al 28/07/25.
Conclusioni chiave: La crescita organica e per acquisizioni rimane solida, ma il livello di indebitamento, gli ammortamenti e gli obblighi TRA pesano sugli utili netti e sulla liquidità.
RYAN Q2-25 (10-Q) puntos destacados:
- Los ingresos totales aumentaron un 23% interanual hasta 855,2 M$, impulsados por Wholesale Brokerage +7%, Binding Authority +17% y un aumento del 73% en Underwriting Management.
- El ingreso operativo creció un 16% hasta 191,1 M$; el margen operativo bajó 120 puntos básicos hasta el 22,3% debido a que la compensación y amortización superaron el crecimiento de los ingresos.
- La utilidad neta atribuible a RYAN aumentó un 11% a 52,0 M$; el EPS diluido subió a 0,38$ (frente a 0,37$).
- Vista a seis meses: ingresos +24% a 1,55 B$, pero EPS cayó un 63% a 0,18$ debido a un aumento pronunciado en amortización (+130%) y gastos por intereses (+86%).
- Los gastos por intereses aumentaron a 58,3 M$ en el trimestre, reflejando mayores préstamos; la deuda a largo plazo ahora es de 3,41 B$ (+6% en lo que va del año).
- El efectivo y equivalentes cayeron a 172,6 M$ (-68% en lo que va del año) tras gastar 565 M$ en tres adquisiciones: Velocity Risk Underwriters, USQRisk Holdings y 360° Underwriting. El goodwill aumentó a 3,09 B$.
- El flujo de caja operativo mejoró un 37% hasta 210,8 M$; sin embargo, el flujo de caja libre fue negativo debido al gasto en adquisiciones.
- Acciones en circulación: 128,0 M Clase A, 135,7 M Clase B al 28/07/25.
Conclusiones clave: El crecimiento orgánico y por adquisiciones continúa fuerte, pero el apalancamiento, los cargos por amortización y las obligaciones TRA están afectando las ganancias netas y la liquidez.
RYAN 2분기 25 (10-Q) 주요 내용:
- 총수익이 전년 대비 23% 증가한 8억 5,520만 달러를 기록했으며, 도매 중개 +7%, 바인딩 권한 +17% 및 언더라이팅 관리가 73% 급증한 데 힘입음.
- 영업이익은 16% 증가한 1억 9,110만 달러; 보상 및 상각 비용 증가로 영업 마진은 120bp 하락한 22.3% 기록.
- RYAN 귀속 순이익은 11% 증가한 5,200만 달러; 희석 주당순이익(EPS)은 0.38달러로 상승(이전 0.37달러 대비).
- 6개월 전망: 수익 24% 증가한 15억 5천만 달러, 그러나 상각비(+130%) 및 이자 비용(+86%) 급증으로 EPS는 63% 감소한 0.18달러.
- 분기 이자 비용은 차입 증가를 반영하여 5,830만 달러로 상승; 장기 부채는 현재 34억 1천만 달러로 연초 대비 6% 증가.
- 현금 및 현금성 자산은 6억 1,726만 달러로 연초 대비 68% 감소, 5억 6,500만 달러를 세 건의 인수( Velocity Risk Underwriters, USQRisk Holdings, 360° Underwriting)에 지출함. 영업권은 30억 9천만 달러로 증가.
- 영업 현금 흐름은 37% 개선되어 2억 1,080만 달러 기록; 다만 인수 지출로 인해 자유 현금 흐름은 마이너스.
- 발행 주식 수: 7/28/25 기준 클래스 A 1억 2,800만 주, 클래스 B 1억 3,570만 주.
주요 시사점: 강력한 유기적 및 인수 성장세가 지속되나, 레버리지, 상각비 및 TRA 의무가 순이익과 유동성에 부담으로 작용 중.
RYAN T2-25 (10-Q) points clés :
- Le chiffre d'affaires total a augmenté de 23 % en glissement annuel pour atteindre 855,2 M$, porté par Wholesale Brokerage +7%, Binding Authority +17% et une hausse de 73 % du Underwriting Management.
- Le résultat d'exploitation a progressé de 16 % pour atteindre 191,1 M$ ; la marge d'exploitation a reculé de 120 points de base à 22,3 % en raison d'une hausse des rémunérations et des amortissements supérieure à la croissance du chiffre d'affaires.
- Le résultat net attribuable à RYAN a augmenté de 11 % pour atteindre 52,0 M$ ; le BPA dilué est passé à 0,38$ (contre 0,37$).
- Sur six mois : chiffre d'affaires +24 % à 1,55 Md$, mais le BPA a chuté de 63 % à 0,18$ en raison d'une forte hausse des amortissements (+130 %) et des charges d'intérêts (+86 %).
- Les charges d'intérêts ont augmenté à 58,3 M$ au cours du trimestre, reflétant un endettement plus élevé ; la dette à long terme s'élève désormais à 3,41 Md$ (+6 % depuis le début de l'année).
- La trésorerie et les équivalents ont chuté à 172,6 M$ (-68 % depuis le début de l'année) après un décaissement de 565 M$ pour trois acquisitions : Velocity Risk Underwriters, USQRisk Holdings et 360° Underwriting. Le goodwill a augmenté à 3,09 Md$.
- Le flux de trésorerie d'exploitation s'est amélioré de 37 % à 210,8 M$ ; cependant, le flux de trésorerie disponible était négatif en raison des dépenses liées aux acquisitions.
- Actions en circulation : 128,0 M de classe A, 135,7 M de classe B au 28/07/25.
Points clés : La croissance organique et par acquisitions reste solide, mais l'effet de levier, les charges d'amortissement et les obligations TRA pèsent sur les bénéfices nets et la liquidité.
RYAN Q2-25 (10-Q) Highlights:
- Der Gesamtumsatz stieg im Jahresvergleich um 23 % auf 855,2 Mio. $, angetrieben durch Wholesale Brokerage +7%, Binding Authority +17% und einen 73%igen Anstieg im Underwriting Management.
- Das Betriebsergebnis wuchs um 16 % auf 191,1 Mio. $; die operative Marge sank um 120 Basispunkte auf 22,3 %, da Vergütungen und Abschreibungen das Umsatzwachstum überstiegen.
- Der dem Unternehmen RYAN zurechenbare Nettogewinn stieg um 11 % auf 52,0 Mio. $; das verwässerte Ergebnis je Aktie (EPS) stieg auf 0,38 $ (vorher 0,37 $).
- Sechsmonatsbetrachtung: Umsatz +24 % auf 1,55 Mrd. $, aber das EPS fiel um 63 % auf 0,18 $ aufgrund stark gestiegener Abschreibungen (+130 %) und Zinsaufwendungen (+86 %).
- Die Zinsaufwendungen stiegen im Quartal auf 58,3 Mio. $, was höhere Kreditaufnahmen widerspiegelt; die langfristigen Schulden liegen nun bei 3,41 Mrd. $ (+6 % seit Jahresbeginn).
- Barmittel und Zahlungsmitteläquivalente sanken auf 172,6 Mio. $ (-68 % seit Jahresbeginn) nach einem Baraufwand von 565 Mio. $ für drei Akquisitionen: Velocity Risk Underwriters, USQRisk Holdings und 360° Underwriting. Der Firmenwert stieg auf 3,09 Mrd. $.
- Der operative Cashflow verbesserte sich um 37 % auf 210,8 Mio. $; der freie Cashflow war jedoch aufgrund der Akquisitionsausgaben negativ.
- Ausstehende Aktien: 128,0 Mio. Klasse A, 135,7 Mio. Klasse B zum 28.07.25.
Wesentliche Erkenntnisse: Starkes organisches und akquisitorisches Wachstum setzt sich fort, jedoch belasten Verschuldung, Abschreibungen und TRA-Verpflichtungen den Nettogewinn und die Liquidität.
- 23% YoY revenue growth driven by strength in all three specialties.
- Operating cash flow +37% to $211 M, indicating strong underlying cash generation.
- Strategic $565 M acquisitions expand catastrophe, bespoke risk and construction underwriting platforms.
- Diluted EPS YTD down 63% due to higher amortization and interest costs.
- Interest expense +87% YoY; interest-coverage ratio weakening.
- Cash balance fell 68% while net debt increased to $3.3 B, pressuring liquidity.
- Goodwill and intangibles now represent a significant 44% of total assets, raising future impairment risk.
Insights
TL;DR – Solid top-line beat, but leverage and amortization mute bottom-line.
Revenue growth above 20% confirms RYAN’s ability to capture E&S market share, with Underwriting Management scaling fastest. Gross margin is intact, yet compensation and amortization from recent deals compressed operating leverage modestly. Net debt/EBITDA edges toward 3.7×, and interest cost almost doubled, a trend to monitor if rates stay elevated. The Velocity/USQ/360 buys add niche capabilities and should be accretive once integration synergies arrive, but they front-load PPA amortization, explaining the sharp YTD EPS decline. Liquidity tightened—cash now only 5% of current liabilities—raising reliance on the upsized $1.4 B revolver. Overall impact: mixed; growth narrative intact, but balance-sheet risk is higher.
TL;DR – Leverage rise and cash drain offset healthy cash flow.
Operating cash of $211 M easily covers interest, yet $619 M net investing outflow pushed free cash negative. Long-term debt climbed $179 M and TRA liabilities total $461 M. Interest-coverage (EBIT/interest) fell to 3.3× from 5.3× YoY—still serviceable but trending lower. Goodwill/intangibles now 44% of assets, elevating impairment risk if acquisition targets underperform. Revolver capacity remains, but covenant headroom will shrink if EBITDA momentum stalls. Credit profile is stable near term; outlook hinges on successful integration and margin recovery.
RYAN Q2-25 (10-Q) punti salienti:
- I ricavi totali sono aumentati del 23% su base annua, raggiungendo 855,2 M$, trainati da Wholesale Brokerage +7%, Binding Authority +17% e un incremento del 73% in Underwriting Management.
- L'utile operativo è cresciuto del 16% a 191,1 M$; il margine operativo è sceso di 120 punti base al 22,3% a causa di compensi e ammortamenti superiori alla crescita dei ricavi.
- L'utile netto attribuibile a RYAN è aumentato dell'11% a 52,0 M$; l'EPS diluito è salito a 0,38$ (da 0,37$).
- Vista a sei mesi: ricavi +24% a 1,55 Mld$, ma EPS in calo del 63% a 0,18$ per effetto di ammortamenti (+130%) e oneri finanziari (+86%) significativamente più elevati.
- Le spese per interessi sono salite a 58,3 M$ nel trimestre, riflettendo maggiori indebitamenti; il debito a lungo termine è ora di 3,41 Mld$ (+6% da inizio anno).
- Liquidità e equivalenti sono scesi a 172,6 M$ (-68% da inizio anno) dopo una spesa in contanti di 565 M$ per tre acquisizioni: Velocity Risk Underwriters, USQRisk Holdings e 360° Underwriting. L'avviamento è salito a 3,09 Mld$.
- Il flusso di cassa operativo è migliorato del 37% a 210,8 M$; tuttavia il flusso di cassa libero è negativo a causa delle spese per acquisizioni.
- Azioni in circolazione: 128,0 M di Classe A, 135,7 M di Classe B al 28/07/25.
Conclusioni chiave: La crescita organica e per acquisizioni rimane solida, ma il livello di indebitamento, gli ammortamenti e gli obblighi TRA pesano sugli utili netti e sulla liquidità.
RYAN Q2-25 (10-Q) puntos destacados:
- Los ingresos totales aumentaron un 23% interanual hasta 855,2 M$, impulsados por Wholesale Brokerage +7%, Binding Authority +17% y un aumento del 73% en Underwriting Management.
- El ingreso operativo creció un 16% hasta 191,1 M$; el margen operativo bajó 120 puntos básicos hasta el 22,3% debido a que la compensación y amortización superaron el crecimiento de los ingresos.
- La utilidad neta atribuible a RYAN aumentó un 11% a 52,0 M$; el EPS diluido subió a 0,38$ (frente a 0,37$).
- Vista a seis meses: ingresos +24% a 1,55 B$, pero EPS cayó un 63% a 0,18$ debido a un aumento pronunciado en amortización (+130%) y gastos por intereses (+86%).
- Los gastos por intereses aumentaron a 58,3 M$ en el trimestre, reflejando mayores préstamos; la deuda a largo plazo ahora es de 3,41 B$ (+6% en lo que va del año).
- El efectivo y equivalentes cayeron a 172,6 M$ (-68% en lo que va del año) tras gastar 565 M$ en tres adquisiciones: Velocity Risk Underwriters, USQRisk Holdings y 360° Underwriting. El goodwill aumentó a 3,09 B$.
- El flujo de caja operativo mejoró un 37% hasta 210,8 M$; sin embargo, el flujo de caja libre fue negativo debido al gasto en adquisiciones.
- Acciones en circulación: 128,0 M Clase A, 135,7 M Clase B al 28/07/25.
Conclusiones clave: El crecimiento orgánico y por adquisiciones continúa fuerte, pero el apalancamiento, los cargos por amortización y las obligaciones TRA están afectando las ganancias netas y la liquidez.
RYAN 2분기 25 (10-Q) 주요 내용:
- 총수익이 전년 대비 23% 증가한 8억 5,520만 달러를 기록했으며, 도매 중개 +7%, 바인딩 권한 +17% 및 언더라이팅 관리가 73% 급증한 데 힘입음.
- 영업이익은 16% 증가한 1억 9,110만 달러; 보상 및 상각 비용 증가로 영업 마진은 120bp 하락한 22.3% 기록.
- RYAN 귀속 순이익은 11% 증가한 5,200만 달러; 희석 주당순이익(EPS)은 0.38달러로 상승(이전 0.37달러 대비).
- 6개월 전망: 수익 24% 증가한 15억 5천만 달러, 그러나 상각비(+130%) 및 이자 비용(+86%) 급증으로 EPS는 63% 감소한 0.18달러.
- 분기 이자 비용은 차입 증가를 반영하여 5,830만 달러로 상승; 장기 부채는 현재 34억 1천만 달러로 연초 대비 6% 증가.
- 현금 및 현금성 자산은 6억 1,726만 달러로 연초 대비 68% 감소, 5억 6,500만 달러를 세 건의 인수( Velocity Risk Underwriters, USQRisk Holdings, 360° Underwriting)에 지출함. 영업권은 30억 9천만 달러로 증가.
- 영업 현금 흐름은 37% 개선되어 2억 1,080만 달러 기록; 다만 인수 지출로 인해 자유 현금 흐름은 마이너스.
- 발행 주식 수: 7/28/25 기준 클래스 A 1억 2,800만 주, 클래스 B 1억 3,570만 주.
주요 시사점: 강력한 유기적 및 인수 성장세가 지속되나, 레버리지, 상각비 및 TRA 의무가 순이익과 유동성에 부담으로 작용 중.
RYAN T2-25 (10-Q) points clés :
- Le chiffre d'affaires total a augmenté de 23 % en glissement annuel pour atteindre 855,2 M$, porté par Wholesale Brokerage +7%, Binding Authority +17% et une hausse de 73 % du Underwriting Management.
- Le résultat d'exploitation a progressé de 16 % pour atteindre 191,1 M$ ; la marge d'exploitation a reculé de 120 points de base à 22,3 % en raison d'une hausse des rémunérations et des amortissements supérieure à la croissance du chiffre d'affaires.
- Le résultat net attribuable à RYAN a augmenté de 11 % pour atteindre 52,0 M$ ; le BPA dilué est passé à 0,38$ (contre 0,37$).
- Sur six mois : chiffre d'affaires +24 % à 1,55 Md$, mais le BPA a chuté de 63 % à 0,18$ en raison d'une forte hausse des amortissements (+130 %) et des charges d'intérêts (+86 %).
- Les charges d'intérêts ont augmenté à 58,3 M$ au cours du trimestre, reflétant un endettement plus élevé ; la dette à long terme s'élève désormais à 3,41 Md$ (+6 % depuis le début de l'année).
- La trésorerie et les équivalents ont chuté à 172,6 M$ (-68 % depuis le début de l'année) après un décaissement de 565 M$ pour trois acquisitions : Velocity Risk Underwriters, USQRisk Holdings et 360° Underwriting. Le goodwill a augmenté à 3,09 Md$.
- Le flux de trésorerie d'exploitation s'est amélioré de 37 % à 210,8 M$ ; cependant, le flux de trésorerie disponible était négatif en raison des dépenses liées aux acquisitions.
- Actions en circulation : 128,0 M de classe A, 135,7 M de classe B au 28/07/25.
Points clés : La croissance organique et par acquisitions reste solide, mais l'effet de levier, les charges d'amortissement et les obligations TRA pèsent sur les bénéfices nets et la liquidité.
RYAN Q2-25 (10-Q) Highlights:
- Der Gesamtumsatz stieg im Jahresvergleich um 23 % auf 855,2 Mio. $, angetrieben durch Wholesale Brokerage +7%, Binding Authority +17% und einen 73%igen Anstieg im Underwriting Management.
- Das Betriebsergebnis wuchs um 16 % auf 191,1 Mio. $; die operative Marge sank um 120 Basispunkte auf 22,3 %, da Vergütungen und Abschreibungen das Umsatzwachstum überstiegen.
- Der dem Unternehmen RYAN zurechenbare Nettogewinn stieg um 11 % auf 52,0 Mio. $; das verwässerte Ergebnis je Aktie (EPS) stieg auf 0,38 $ (vorher 0,37 $).
- Sechsmonatsbetrachtung: Umsatz +24 % auf 1,55 Mrd. $, aber das EPS fiel um 63 % auf 0,18 $ aufgrund stark gestiegener Abschreibungen (+130 %) und Zinsaufwendungen (+86 %).
- Die Zinsaufwendungen stiegen im Quartal auf 58,3 Mio. $, was höhere Kreditaufnahmen widerspiegelt; die langfristigen Schulden liegen nun bei 3,41 Mrd. $ (+6 % seit Jahresbeginn).
- Barmittel und Zahlungsmitteläquivalente sanken auf 172,6 Mio. $ (-68 % seit Jahresbeginn) nach einem Baraufwand von 565 Mio. $ für drei Akquisitionen: Velocity Risk Underwriters, USQRisk Holdings und 360° Underwriting. Der Firmenwert stieg auf 3,09 Mrd. $.
- Der operative Cashflow verbesserte sich um 37 % auf 210,8 Mio. $; der freie Cashflow war jedoch aufgrund der Akquisitionsausgaben negativ.
- Ausstehende Aktien: 128,0 Mio. Klasse A, 135,7 Mio. Klasse B zum 28.07.25.
Wesentliche Erkenntnisse: Starkes organisches und akquisitorisches Wachstum setzt sich fort, jedoch belasten Verschuldung, Abschreibungen und TRA-Verpflichtungen den Nettogewinn und die Liquidität.

(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) | |||
(Address of principal executive offices) | (Zip Code) |
( |
(Registrant’s telephone number, including area code) |
Title of each class | Trading symbol | Name of each exchange on which registered | ||
☒ | Accelerated filer | ☐ | ||
Non-accelerated filer | ☐ | Smaller reporting company | ||
Emerging growth company |
PART I. FINANCIAL INFORMATION | 1 | |
Item 1. | Financial Statements | 1 |
Consolidated Statements of Income (Unaudited) | 1 | |
Consolidated Statements of Comprehensive Income (Unaudited) | 2 | |
Consolidated Balance Sheets (Unaudited) | 3 | |
Consolidated Statements of Cash Flows (Unaudited) | 4 | |
Consolidated Statements of Stockholders’ Equity (Unaudited) | 5 | |
Notes to the Consolidated Financial Statements (Unaudited) | 7 | |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 33 |
Item 3. | Quantitative and Qualitative Disclosure About Market Risk | 54 |
Item 4. | Controls and Procedures | 55 |
PART II. OTHER INFORMATION | 56 | |
Item 1. | Legal Proceedings | 56 |
Item 1A. | Risk Factors | 56 |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 56 |
Item 3. | Defaults Upon Senior Securities | 56 |
Item 4. | Mine Safety Disclosures | 56 |
Item 5. | Other Information | 56 |
Item 6. | Exhibits | 57 |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
REVENUE | ||||||||
Net commissions and fees | $ | $ | $ | $ | ||||
Fiduciary investment income | ||||||||
Total revenue | $ | $ | $ | $ | ||||
EXPENSES | ||||||||
Compensation and benefits | ||||||||
General and administrative | ||||||||
Amortization | ||||||||
Depreciation | ||||||||
Change in contingent consideration | ( | ( | ||||||
Total operating expenses | $ | $ | $ | $ | ||||
OPERATING INCOME | $ | $ | $ | $ | ||||
Interest expense, net | ||||||||
Income from equity method investments | ( | ( | ( | ( | ||||
Other non-operating loss (income) | ( | |||||||
INCOME BEFORE INCOME TAXES | $ | $ | $ | $ | ||||
Income tax expense | ||||||||
NET INCOME | $ | $ | $ | $ | ||||
Net income attributable to non-controlling interests, net of tax | ||||||||
NET INCOME ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $ | $ | $ | ||||
NET INCOME PER SHARE OF CLASS A COMMON STOCK: | ||||||||
Basic | $ | $ | $ | $ | ||||
Diluted | $ | $ | $ | $ | ||||
WEIGHTED-AVERAGE SHARES OF CLASS A COMMON STOCK OUTSTANDING: | ||||||||
Basic | ||||||||
Diluted |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
NET INCOME | $ | $ | $ | $ | ||||
Net income attributable to non-controlling interests, net of tax | ||||||||
NET INCOME ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $ | $ | $ | ||||
Other comprehensive income (loss), net of tax: | ||||||||
Gain on interest rate cap | ||||||||
(Gain) on interest rate cap reclassified to earnings | ( | ( | ( | ( | ||||
Foreign currency translation adjustments | ||||||||
Change in share of equity method investments’ other comprehensive income (loss) | ( | ( | ||||||
Total other comprehensive income (loss), net of tax | $ | $( | $ | $ | ||||
COMPREHENSIVE INCOME ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $ | $ | $ |
June 30, 2025 | December 31, 2024 | |||
ASSETS | ||||
CURRENT ASSETS | ||||
Cash and cash equivalents | $ | $ | ||
Commissions and fees receivable – net | ||||
Fiduciary cash and receivables | ||||
Prepaid incentives – net | ||||
Other current assets | ||||
Total current assets | $ | $ | ||
NON-CURRENT ASSETS | ||||
Goodwill | ||||
Customer relationships | ||||
Other intangible assets | ||||
Prepaid incentives – net | ||||
Equity method investments | ||||
Property and equipment – net | ||||
Lease right-of-use assets | ||||
Deferred tax assets | ||||
Other non-current assets | ||||
Total non-current assets | $ | $ | ||
TOTAL ASSETS | $ | $ | ||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
CURRENT LIABILITIES | ||||
Accounts payable and accrued liabilities | $ | $ | ||
Accrued compensation | ||||
Operating lease liabilities | ||||
Tax Receivable Agreement liabilities | ||||
Short-term debt and current portion of long-term debt | ||||
Fiduciary liabilities | ||||
Total current liabilities | $ | $ | ||
NON-CURRENT LIABILITIES | ||||
Accrued compensation | ||||
Operating lease liabilities | ||||
Long-term debt | ||||
Tax Receivable Agreement liabilities | ||||
Deferred tax liabilities | ||||
Other non-current liabilities | ||||
Total non-current liabilities | $ | $ | ||
TOTAL LIABILITIES | $ | $ | ||
STOCKHOLDERS’ EQUITY | ||||
Class A common stock ($ outstanding at June 30, 2025 and December 31, 2024, respectively) | ||||
Class B common stock ($ outstanding at June 30, 2025 and December 31, 2024, respectively) | ||||
Class X common stock ($ authorized, | ||||
Preferred stock ($ December 31, 2024) | ||||
Additional paid-in capital | ||||
Retained earnings | ||||
Accumulated other comprehensive income (loss) | ( | |||
Total stockholders’ equity attributable to Ryan Specialty Holdings, Inc. | $ | $ | ||
Non-controlling interests | ||||
Total stockholders’ equity | $ | $ | ||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | $ |
Six Months Ended June 30, | ||||
2025 | 2024 | |||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||
Net income | $ | $ | ||
Adjustments to reconcile net income to cash flows provided by operating activities: | ||||
Income from equity method investments | ( | ( | ||
Amortization | ||||
Depreciation | ||||
Prepaid and deferred compensation expense | ||||
Non-cash equity-based compensation | ||||
Amortization of deferred debt issuance costs | ||||
Amortization of interest rate cap premium | ||||
Deferred income tax expense | ||||
Deferred income tax expense from common control reorganization | ||||
Loss on Tax Receivable Agreement | ||||
Changes in operating assets and liabilities, net of acquisitions: | ||||
Commissions and fees receivable – net | ( | ( | ||
Accrued interest liability | ( | |||
Other current and non-current assets | ||||
Other current and non-current accrued liabilities | ( | ( | ||
Total cash flows provided by operating activities | $ | $ | ||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||
Business combinations – net of cash acquired and cash held in a fiduciary capacity | ( | ( | ||
Capital expenditures | ( | ( | ||
Equity method investment in VSIC | ( | |||
Asset acquisitions | ( | |||
Total cash flows used in investing activities | $( | $( | ||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||
Borrowings on Revolving Credit Facility | ||||
Repayments on Revolving Credit Facility | ( | |||
Debt issuance costs paid | ( | |||
Repayment of term debt | ( | ( | ||
Receipt of contingently returnable consideration | ||||
Payment of contingent consideration | ( | |||
Tax distributions to non-controlling LLC Unitholders | ( | ( | ||
Receipt of taxes related to net share settlement of equity awards | ||||
Taxes paid related to net share settlement of equity awards | ( | ( | ||
Class A common stock dividends and Dividend Equivalents paid | ( | ( | ||
Distributions and Declared Distributions paid to non-controlling LLC Unitholders | ( | ( | ||
Payment of accrued return on Ryan Re preferred units | ( | ( | ||
Net change in fiduciary liabilities | ||||
Total cash flows provided by financing activities | $ | $ | ||
Effect of changes in foreign exchange rates on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | ( | |||
NET CHANGE IN CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY | $( | $( | ||
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY—Beginning balance | ||||
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY—Ending balance | $ | $ | ||
Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | ||||
Cash and cash equivalents | $ | $ | ||
Cash and cash equivalents held in a fiduciary capacity | ||||
Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | $ | $ |
Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Non- controlling Interests | Total Stockholders’ Equity | ||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||
Balance at December 31, 2024 | $ | $ | $ | $ | $( | $ | $ | |||||||||||
Net income (loss) | — | — | — | — | — | ( | — | ( | ||||||||||
Issuance of common stock | — | — | — | — | — | — | — | — | ||||||||||
Exchange of LLC equity for common stock | ( | — | — | — | ( | |||||||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non-controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | ( | ||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investment’s other comprehensive loss | — | — | — | — | — | — | ( | ( | ( | |||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ||||||||||||
Equity-based compensation | — | — | — | — | — | — | ( | |||||||||||
Balance at March 31, 2025 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | — | — | — | — | — | |||||||||||
Exchange of LLC equity for common stock | ( | ( | — | — | ( | |||||||||||||
Forfeiture of common stock | ( | — | — | — | — | — | — | — | — | |||||||||
Equity awards withheld for settlement of employee tax obligations | — | — | — | — | ( | — | — | ( | ( | |||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non-controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | — | — | — | |||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investments’ other comprehensive income | — | — | — | — | — | — | ||||||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ||||||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at June 30, 2025 | $ | $ | $ | $ | $ | $ | $ |
Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income | Non- controlling Interests | Total Stockholders’ Equity | ||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||
Balance at December 31, 2023 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | — | — | — | — | — | — | ||||||||||
Exchange of LLC equity for common stock | — | ( | — | — | — | ( | ||||||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non-controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | — | ( | |||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investment’s other comprehensive income | — | — | — | — | — | — | ||||||||||||
Gain on interest rate cap, net | — | — | — | — | — | — | ||||||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ( | ( | ( | |||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at March 31, 2024 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | — | — | ||||||||||||||
Exchange of LLC equity for common stock | — | ( | — | — | — | ( | ||||||||||||
Equity awards withheld for settlement of employee tax obligations | — | — | — | — | — | — | ( | ( | ||||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non-controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | — | — | ( | |||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investment’s other comprehensive income | — | — | — | — | — | — | ( | ( | ( | |||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ||||||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at June 30, 2024 | $ | $ | $ | $ | $ | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Wholesale Brokerage | $ | $ | $ | $ | ||||
Binding Authority | ||||||||
Underwriting Management | ||||||||
Total Net commissions and fees | $ | $ | $ | $ |
Velocity | USQ | 360 | Total | |||||
Cash and cash equivalents | $ | $ | $ | $ | ||||
Commissions and fees receivable – net | ||||||||
Fiduciary cash and receivables | ||||||||
Goodwill | ||||||||
Customer relationships1 | ||||||||
Other intangible assets | ||||||||
Lease right-of-use assets | ||||||||
Other current and non-current assets | ||||||||
Total assets acquired | $ | $ | $ | $ | ||||
Accounts payable and accrued liabilities | ||||||||
Accrued compensation | ||||||||
Fiduciary liabilities | ||||||||
Operating lease liabilities | ||||||||
Deferred tax liabilities | ||||||||
Total liabilities assumed | $ | $ | $ | $ | ||||
Net assets acquired | $ | $ | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Total revenue | $ | $ | $ | $ | ||||
Net income (loss) | ( |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Change in contingent consideration | $( | $ | $( | $ | ||||
Interest expense, net | ||||||||
Total | $ | $ | $( | $ |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Beginning of period | $ | $ | $ | $ | ||||
Write-offs | ( | ( | ( | ( | ||||
Increase in provision | ||||||||
End of period | $ | $ | $ | $ |
June 30, 2025 | December 31, 2024 | |||
Prepaid expenses | $ | $ | ||
Insurance recoverable | ||||
Interest rate cap | ||||
Other current receivables | ||||
Total Other current assets | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||
2025 | 2024 | 2025 | 2024 | ||||||
Lease costs | |||||||||
Operating lease costs | $ | $ | $ | $ | |||||
Short-term lease costs | |||||||||
Operating lease costs | |||||||||
Sublease income | ( | ( | ( | ( | |||||
Lease costs – net | $ | $ | $ | $ | |||||
Cash paid for amounts included in the measurement of lease liabilities | |||||||||
Operating cash flows for operating leases | $ | $ | |||||||
Non-cash related activities | |||||||||
Right-of-use assets obtained in exchange for new operating lease liabilities | |||||||||
Amortization of right-of-use assets for operating lease activity | |||||||||
Weighted average discount rate (percent) | |||||||||
Operating leases | |||||||||
Weighted average remaining lease term (years) | |||||||||
Operating leases |
June 30, 2025 | December 31, 2024 | |||
Term debt | ||||
payments, Adjusted Term SOFR + | $ | $ | ||
Senior secured notes | ||||
mature | ||||
mature August 1, 2032 | ||||
Revolving debt | ||||
SOFR + up to | ||||
Premium financing notes | ||||
Commercial notes, periodic interest and principal payments, expire May 1, 2026 | ||||
Commercial notes, periodic interest and principal payments, expired | ||||
Commercial notes, periodic interest and principal payments, expired | ||||
Commercial notes, periodic interest and principal payments, expired | ||||
Units subject to mandatory redemption | ||||
Total debt | $ | $ | ||
Less: Short-term debt and current portion of long-term debt | ( | ( | ||
Long-term debt | $ | $ |
Six Months Ended June 30, 2025 | |||||||||
Restricted Stock | Weighted Average Grant Date Fair Value | Restricted Common Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | |||||||||
Forfeited | ( | ||||||||
Unvested at end of period | $ | $ |
Six Months Ended June 30, 2025 | |||||||||
IPO RSUs | Incentive RSUs | ||||||||
Restricted Stock Units | Weighted Average Grant Date Fair Value | Restricted Stock Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | ( | ( | |||||||
Forfeited | ( | ( | |||||||
Unvested at end of period | $ | $ |
Six Months Ended June 30, 2025 | |||||||||
Reload Options1 | Staking Options1 | Incentive Options | Incentive Options Weighted Average Exercise Price | ||||||
Outstanding at beginning of period | $ | ||||||||
Granted | |||||||||
Exercised | ( | ( | |||||||
Forfeited | |||||||||
Outstanding at end of period | $ |
Aggregate intrinsic value ($ in thousands): | ||
Reload Options outstanding | $ | |
Reload Options exercisable | ||
Staking Options outstanding | ||
Staking Options exercisable | ||
Incentive Options outstanding | ||
Incentive Options exercisable | ||
Weighted-average remaining contractual term (in years): | ||
Reload Options outstanding | ||
Reload Options exercisable | ||
Staking Options outstanding | ||
Staking Options exercisable | ||
Incentive Options outstanding | ||
Incentive Options exercisable |
Six Months Ended June 30, 2025 | |||||||||
IPO RLUs | Incentive RLUs | ||||||||
Restricted LLC Units | Weighted Average Grant Date Fair Value | Restricted LLC Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | ( | ||||||||
Forfeited | |||||||||
Unvested at end of period | $ | $ |
Six Months Ended June 30, 2025 | |||||||||
Reload Class C Incentive Units | Staking Class C Incentive Units | Class C Incentive Units | Class C Incentive Units Weighted Average Participation Threshold | ||||||
Unvested at beginning of period | $ | ||||||||
Granted | |||||||||
Vested | ( | ||||||||
Forfeited | |||||||||
Unvested at end of period | $ |
Six Months Ended June 30, 2025 | |||||||||
PSUs | PLUs | ||||||||
Performance Stock Units | Weighted Average Grant Date Fair Value | Performance LLC Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | |||||||||
Forfeited | ( | ||||||||
Unvested at end of period | $ | $ |
Volatility | ||
Time to maturity (years) | ||
Risk-free rate | ||
RYAN stock price at valuation date | $ |
Amount | Weighted Average Remaining Expense Period (Years) | |||
Restricted Stock | $ | |||
IPO RSUs | ||||
Incentive RSUs | ||||
Reload Options | ||||
Incentive Options | ||||
PSUs | ||||
Restricted Common Units | ||||
IPO RLUs | ||||
Incentive RLUs | ||||
Reload Class C Incentive Units | ||||
Staking Class C Incentive Units | ||||
Class C Incentive Units | ||||
PLUs | ||||
Total unrecognized equity-based compensation expense | $ |
Recognized | Unrecognized | |||||||||
Three Months Ended June 30, | Six Months Ended June 30, | As of June 30, 2025 | ||||||||
2025 | 2024 | 2025 | 2024 | |||||||
IPO awards | ||||||||||
IPO RSUs and Staking Options | $ | $ | $ | $ | $ | |||||
IPO RLUs and Staking Class C Incentive Units | ||||||||||
Incremental Restricted Stock and Reload Options | ||||||||||
Incremental Restricted Common Units and Reload Class C Incentive Units | ||||||||||
Pre-IPO incentive awards | ||||||||||
Restricted Stock | ||||||||||
Restricted Common Units | ||||||||||
Post-IPO incentive awards | ||||||||||
Incentive RSUs | ||||||||||
Incentive RLUs | ||||||||||
Incentive Options | ||||||||||
Class C Incentive Units | ||||||||||
PSUs | ||||||||||
PLUs | ||||||||||
Other expense | ||||||||||
Director Stock Grants | ||||||||||
Total equity-based compensation expense | $ | $ | $ | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Net income | $ | $ | $ | $ | ||||
Less: Net income attributable to non-controlling interests | ||||||||
Net income attributable to Ryan Specialty Holdings, Inc. | $ | $ | $ | $ | ||||
Numerator: | ||||||||
Net income attributable to Class A common shareholders | $ | $ | $ | $ | ||||
Less: Income attributed to substantively vested RSUs | ( | ( | ||||||
Net income attributable to Class A common shareholders – basic | $ | $ | $ | $ | ||||
Add: Income attributed to dilutive shares | ||||||||
Net income attributable to Class A common shareholders – diluted | $ | $ | $ | $ | ||||
Denominator: | ||||||||
Weighted-average shares of Class A common stock outstanding – basic | ||||||||
Add: Dilutive shares | ||||||||
Weighted-average shares of Class A common stock outstanding – diluted | ||||||||
Earnings per share | ||||||||
Earnings per share of Class A common stock – basic | $ | $ | $ | $ | ||||
Earnings per share of Class A common stock – diluted | $ | $ | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Conversion of non-controlling interest LLC Common Units1 | ||||||||
Incentive Options | ||||||||
Class C Incentive Units |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||
Income Statement Caption | 2025 | 2024 | 2025 | 2024 | |||||
Change in the fair value of the Deal-Contingent Forward | General and administrative | $ | $( | $ | $( | ||||
Total impact of derivatives not designated as hedging instruments | $ | $( | $ | $( | |||||
Interest rate cap premium amortization | Interest expense, net | $( | $( | $( | $( | ||||
Amounts reclassified out of other comprehensive income related to the interest rate cap | Interest expense, net | ||||||||
Total impact of derivatives designated as hedging instruments | $ | $ | $ | $ |
Balance Sheet Caption | June 30, 2025 | December 31, 2024 | |||
Interest rate cap | Other current assets | $ | $ |
June 30, 2025 | December 31, 2024 | |||||||||||
Level 1 | Level 2 | Level 3 | Level 1 | Level 2 | Level 3 | |||||||
Assets | ||||||||||||
Interest rate cap | $ | $ | $ | $ | $ | $ | ||||||
Contingently returnable consideration | ||||||||||||
Liabilities | ||||||||||||
Contingent consideration | ||||||||||||
Total assets and liabilities measured at fair value | $ | $ | $ | $ | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Assets | ||||||||
Balance at beginning of period | $ | $ | $ | $ | ||||
Newly established assets due to acquisitions | ||||||||
Total gains (losses) included in earnings | ( | |||||||
Total gains included in OCI | ||||||||
Settlements | ( | |||||||
Balance at end of period | $ | $ | $ | $ | ||||
Liabilities | ||||||||
Balance at beginning of period | $ | $ | $ | $ | ||||
Newly established liabilities due to acquisitions | ||||||||
Total (gains) losses included in earnings | ( | |||||||
Total losses included in OCI | ||||||||
Settlements | ( | ( | ( | ( | ||||
Acquisition measurement period adjustments | ( | ( | ||||||
Balance at end of period | $ | $ | $ | $ |
Exchange Tax Attributes | Pre-IPO M&A Tax Attributes | TRA Payment Tax Attributes | TRA Liabilities | |||||
Balance at December 31, 2024 | $ | $ | $ | $ | ||||
Exchange of LLC Common Units | ||||||||
Accrued interest | ||||||||
Balance at June 30, 2025 | $ | $ | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Gain on interest rate cap | $( | $( | $( | $( | ||||
Gain on interest rate cap reclassified to earnings | ||||||||
Foreign currency translation adjustments | ( | ( | ( | ( | ||||
Change in share of equity method investments’ other comprehensive income (loss) | ( | ( |
Gain on Interest Rate Cap | Foreign Currency Translation Adjustments | Change in EMI Other Comprehensive Income (Loss) 1 | Total | |||||
Balance at December 31, 2024 | $ | $( | $( | $( | ||||
Other comprehensive income (loss) before reclassifications | ( | |||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $ | $( | $ | ||||
Less: Non-controlling interests | ( | ( | ||||||
Balance at March 31, 2025 | $ | $ | $( | $ | ||||
Other comprehensive income before reclassifications | ||||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $ | $ | $ | ||||
Less: Non-controlling interests | ( | |||||||
Balance at June 30, 2025 | $ | $ | $( | $ |
Gain on Interest Rate Cap | Foreign Currency Translation Adjustments | Change in EMI Other Comprehensive Income (Loss) 1 | Total | |||||
Balance at December 31, 2023 | $ | $ | $( | $ | ||||
Other comprehensive income (loss) before reclassifications | ( | |||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $ | $( | $ | $ | ||||
Less: Non-controlling interests | ( | |||||||
Balance at March 31, 2024 | $ | $ | $( | $ | ||||
Other comprehensive income (loss) before reclassifications | ( | |||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $ | $( | $( | ||||
Less: Non-controlling interests | ( | ( | ( | |||||
Balance at June 30, 2024 | $ | $ | $( | $ |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Net commissions and fees | $ | $ | $ | $ | ||||
Fiduciary investment income | ||||||||
Total revenue | $ | $ | $ | $ | ||||
Compensation-related expense1 | ||||||||
General and administrative expense2 | ||||||||
Other segment items3 | ||||||||
Depreciation and amortization | ||||||||
Change in contingent consideration | ( | ( | ||||||
Interest income | ( | ( | ( | ( | ||||
Interest expense | ||||||||
Income from equity method investments | ( | ( | ( | ( | ||||
Income tax expense | ||||||||
Other non-operating loss (income) | ( | |||||||
Net income | $ | $ | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
United States | $ | $ | $ | $ | ||||
Foreign | ||||||||
Total revenue | $ | $ | $ | $ |
Six Months Ended June 30, | ||||
2025 | 2024 | |||
Cash paid for: | ||||
Interest, net1 | $ | $ | ||
Income taxes, net of refunds | ||||
Non-cash investing and financing activities: | ||||
Non-controlling interest holders’ tax distributions declared but unpaid | $ | $ | ||
Tax Receivable Agreement liabilities | ||||
Dividend Equivalents and Declared Distributions liabilities | ||||
Contingently returnable consideration | ||||
Contingent consideration liabilities |
Three Months Ended June 30, | Change | Six Months Ended June 30, | Change | |||||||||||||
(in thousands, except percentages and per share data) | 2025 | 2024 | $ | % | 2025 | 2024 | $ | % | ||||||||
Revenue | ||||||||||||||||
Net commissions and fees | $840,857 | $680,248 | $160,609 | 23.6 % | $1,516,985 | $1,218,135 | $298,850 | 24.5 % | ||||||||
Fiduciary investment income | 14,313 | 15,193 | (880) | (5.8) | 28,351 | 29,352 | (1,001) | (3.4) | ||||||||
Total revenue | $855,170 | $695,441 | $159,729 | 23.0 % | $1,545,336 | $1,247,487 | $297,849 | 23.9 % | ||||||||
Expenses | ||||||||||||||||
Compensation and benefits | 485,272 | 414,049 | 71,223 | 17.2 | 915,561 | 787,576 | 127,985 | 16.3 | ||||||||
General and administrative | 107,049 | 82,967 | 24,082 | 29.0 | 213,109 | 158,834 | 54,275 | 34.2 | ||||||||
Amortization | 69,668 | 30,541 | 39,127 | NM | 134,653 | 58,529 | 76,124 | NM | ||||||||
Depreciation | 2,888 | 2,273 | 615 | 27.1 | 5,527 | 4,353 | 1,174 | 27.0 | ||||||||
Change in contingent consideration | (759) | 1,243 | (2,002) | NM | (14,801) | 1,178 | (15,979) | NM | ||||||||
Total operating expenses | $664,118 | $531,073 | $133,045 | 25.1 % | $1,254,049 | $1,010,470 | $243,579 | 24.1 % | ||||||||
Operating income | $191,052 | $164,368 | $26,684 | 16.2 % | $291,287 | $237,017 | $54,270 | 22.9 % | ||||||||
Interest expense, net | 58,334 | 31,128 | 27,206 | 87.4 | 112,842 | 60,528 | 52,314 | 86.4 | ||||||||
(Income) from equity method investments | (5,156) | (3,722) | (1,434) | 38.5 | (10,093) | (9,328) | (765) | 8.2 | ||||||||
Other non-operating loss (income) | 143 | 233 | (90) | (38.6) | (234) | 1,985 | (2,219) | NM | ||||||||
Income before income taxes | $137,731 | $136,729 | $1,002 | 0.7 % | $188,772 | $183,832 | $4,940 | 2.7 % | ||||||||
Income tax expense | 13,026 | 18,691 | (5,665) | (30.3) | 68,456 | 25,117 | 43,339 | NM | ||||||||
Net income | $124,705 | $118,038 | $6,667 | 5.6 % | $120,316 | $158,715 | $(38,399) | (24.2) % | ||||||||
GAAP financial measures | ||||||||||||||||
Total revenue | $855,170 | $695,441 | $159,729 | 23.0 % | $1,545,336 | $1,247,487 | $297,849 | 23.9 % | ||||||||
Net commissions and fees | 840,857 | 680,248 | 160,609 | 23.6 | 1,516,985 | 1,218,135 | 298,850 | 24.5 | ||||||||
Compensation and benefits | 485,272 | 414,049 | 71,223 | 17.2 | 915,561 | 787,576 | 127,985 | 16.3 | ||||||||
General and administrative | 107,049 | 82,967 | 24,082 | 29.0 | 213,109 | 158,834 | 54,275 | 34.2 | ||||||||
Net income | 124,705 | 118,038 | 6,667 | 5.6 | 120,316 | 158,715 | (38,399) | (24.2) | ||||||||
Compensation and benefits expense ratio (1) | 56.7 % | 59.5 % | 59.2 % | 63.1 % | ||||||||||||
General and administrative expense ratio (2) | 12.5 % | 11.9 % | 13.8 % | 12.7 % | ||||||||||||
Net income margin (3) | 14.6 % | 17.0 % | 7.8 % | 12.7 % | ||||||||||||
Earnings per share (4) | $0.41 | $0.38 | $0.19 | $0.52 | ||||||||||||
Diluted earnings per share (4) | $0.38 | $0.37 | $0.18 | $0.49 | ||||||||||||
Non-GAAP financial measures* | ||||||||||||||||
Organic revenue growth rate | 7.1 % | 14.2 % | 9.6 % | 14.0 % | ||||||||||||
Adjusted compensation and benefits expense | $453,414 | $383,960 | $69,454 | 18.1% | $850,842 | $713,982 | $136,860 | 19.2% | ||||||||
Adjusted compensation and benefits expense ratio | 53.0 % | 55.2 % | 55.1 % | 57.2 % | ||||||||||||
Adjusted general and administrative expense | $93,350 | $63,790 | $29,560 | 46.3% | $185,587 | $128,592 | $56,995 | 44.3% | ||||||||
Adjusted general and administrative expense ratio | 10.9 % | 9.2 % | 12.0 % | 10.3 % | ||||||||||||
Adjusted EBITDAC | $308,406 | $247,691 | $60,715 | 24.5% | $508,907 | $404,913 | $103,994 | 25.7% | ||||||||
Adjusted EBITDAC margin | 36.1 % | 35.6 % | 32.9 % | 32.5 % | ||||||||||||
Adjusted net income | $184,682 | $160,554 | $24,128 | 15.0% | $292,521 | $255,971 | $36,550 | 14.3% | ||||||||
Adjusted net income margin | 21.6 % | 23.1 % | 18.9 % | 20.5 % | ||||||||||||
Adjusted diluted earnings per share | $0.66 | $0.58 | $0.08 | 13.8% | $1.05 | $0.93 | $0.12 | 12.9% |
Three Months Ended June 30, | ||||||||||||
(in thousands, except percentages) | 2025 | % of total | 2024 | % of total | Change | |||||||
Wholesale Brokerage | $477,165 | 56.7 % | $444,129 | 65.3 % | $33,036 | 7.4 % | ||||||
Binding Authorities | 94,524 | 11.2 | 80,630 | 11.8 | 13,894 | 17.2 | ||||||
Underwriting Management | 269,168 | 32.1 | 155,489 | 22.9 | 113,679 | 73.1 | ||||||
Total Net commissions and fees | $840,857 | $680,248 | $160,609 | 23.6 % | ||||||||
Three Months Ended June 30, | ||||||||||||
(in thousands, except percentages) | 2025 | % of total | 2024 | % of total | Change | |||||||
Net commissions and policy fees | $787,074 | 93.6 % | $656,938 | 96.6 % | $130,136 | 19.8 % | ||||||
Supplemental and contingent commissions | 35,630 | 4.2 | 8,927 | 1.3 | 26,703 | 299.1 | ||||||
Loss mitigation and other fees | 18,153 | 2.2 | 14,383 | 2.1 | 3,770 | 26.2 | ||||||
Total Net commissions and fees | $840,857 | $680,248 | $160,609 | 23.6 % |
Six Months Ended June 30, | ||||||||||||
(in thousands, except percentages) | 2025 | % of total | 2024 | % of total | Change | |||||||
Wholesale Brokerage | $837,953 | 55.2 % | $767,574 | 63.0 % | $70,379 | 9.2 % | ||||||
Binding Authorities | 196,474 | 13.0 | 169,265 | 13.9 | 27,209 | 16.1 | ||||||
Underwriting Management | 482,558 | 31.8 | 281,296 | 23.1 | 201,262 | 71.5 | ||||||
Total Net commissions and fees | $1,516,985 | $1,218,135 | $298,850 | 24.5 % | ||||||||
Six Months Ended June 30, | ||||||||||||
(in thousands, except percentages) | 2025 | % of total | 2024 | % of total | Change | |||||||
Net commissions and policy fees | $1,411,040 | 93.0 % | $1,151,442 | 94.5 % | $259,598 | 22.5 % | ||||||
Supplemental and contingent commissions | 73,403 | 4.8 | 38,200 | 3.1 | 35,203 | 92.2 | ||||||
Loss mitigation and other fees | 32,542 | 2.2 | 28,492 | 2.4 | 4,050 | 14.2 | ||||||
Total Net commissions and fees | $1,516,985 | $1,218,135 | $298,850 | 24.5 % |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||
(in thousands, except percentages) | 2025 | 2024 | 2025 | 2024 | |||
Current period Net commissions and fees revenue | $840,857 | $680,248 | $1,516,985 | $1,218,135 | |||
Less: Current period contingent commissions | (27,392) | (5,396) | (57,854) | (29,899) | |||
Less: Revenue attributable to sold businesses | (144) | — | (290) | — | |||
Net commissions and fees revenue excluding contingent commissions | $813,321 | $674,852 | $1,458,841 | $1,188,236 | |||
Prior period Net commissions and fees revenue | $680,248 | $573,020 | $1,218,135 | $1,020,533 | |||
Less: Prior year contingent commissions | (5,396) | (4,502) | (29,899) | (26,136) | |||
Less: Revenue attributable to sold businesses | (581) | — | (1,120) | — | |||
Prior period Net commissions and fees revenue excluding contingent commissions | $674,270 | $568,518 | $1,187,116 | $994,396 | |||
Change in Net commissions and fees revenue excluding contingent commissions | $139,051 | $106,334 | $271,725 | $193,840 | |||
Less: Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions | (89,419) | (25,735) | (156,597) | (54,274) | |||
Impact of change in foreign exchange rates | (1,203) | (64) | (952) | (426) | |||
Organic revenue growth (Non-GAAP) | $48,429 | $80,535 | $114,176 | $139,140 | |||
Net commissions and fees revenue growth rate (GAAP) | 23.6 % | 18.7 % | 24.5 % | 19.4 % | |||
Less: Impact of contingent commissions (1) | (3.0) | 0.0 | (1.6) | 0.1 | |||
Net commissions and fees revenue excluding contingent commissions growth rate (2) | 20.6 % | 18.7 % | 22.9 % | 19.5 % | |||
Less: Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions (3) | (13.3) | (4.5) | (13.2) | (5.5) | |||
Impact of change in foreign exchange rates (4) | (0.2) | 0.0 | (0.1) | 0.0 | |||
Organic Revenue Growth Rate (Non-GAAP) | 7.1 % | 14.2 % | 9.6 % | 14.0 % |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
(in thousands, except percentages) | 2025 | 2024 | 2025 | 2024 | ||||
Total revenue | $855,170 | $695,441 | $1,545,336 | $1,247,487 | ||||
Compensation and benefits expense | $485,272 | $414,049 | $915,561 | $787,576 | ||||
Acquisition-related expense | (1,484) | (1,160) | (4,963) | (1,386) | ||||
Acquisition related long-term incentive compensation | (9,321) | (2,891) | (17,652) | (1,264) | ||||
Restructuring and related expense | — | (3,799) | — | (29,983) | ||||
Amortization and expense related to discontinued prepaid incentives | (1,128) | (1,344) | (2,306) | (2,756) | ||||
Equity-based compensation | (14,853) | (12,756) | (29,422) | (22,271) | ||||
Initial public offering related expense | (5,072) | (8,139) | (10,376) | (15,934) | ||||
Adjusted compensation and benefits expense (1) | $453,414 | $383,960 | $850,842 | $713,982 | ||||
Compensation and benefits expense ratio | 56.7 % | 59.5 % | 59.2 % | 63.1 % | ||||
Adjusted compensation and benefits expense ratio | 53.0 % | 55.2 % | 55.1 % | 57.2 % |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
(in thousands, except percentages) | 2025 | 2024 | 2025 | 2024 | ||||
Total revenue | $855,170 | $695,441 | $1,545,336 | $1,247,487 | ||||
General and administrative expense | $107,049 | $82,967 | $213,109 | $158,834 | ||||
Acquisition-related expense | (13,699) | (15,008) | (27,522) | (23,219) | ||||
Restructuring and related expense | — | (4,169) | — | (7,023) | ||||
Adjusted general and administrative expense (1) | $93,350 | $63,790 | $185,587 | $128,592 | ||||
General and administrative expense ratio | 12.5 % | 11.9 % | 13.8 % | 12.7 % | ||||
Adjusted general and administrative expense ratio | 10.9 % | 9.2 % | 12.0 % | 10.3 % |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
(in thousands, except percentages) | 2025 | 2024 | 2025 | 2024 | ||||
Total revenue | $855,170 | $695,441 | $1,545,336 | $1,247,487 | ||||
Net income | $124,705 | $118,038 | $120,316 | $158,715 | ||||
Interest expense, net | 58,334 | 31,128 | 112,842 | 60,528 | ||||
Income tax expense | 13,026 | 18,691 | 68,456 | 25,117 | ||||
Depreciation | 2,888 | 2,273 | 5,527 | 4,353 | ||||
Amortization | 69,668 | 30,541 | 134,653 | 58,529 | ||||
Change in contingent consideration (1) | (759) | 1,243 | (14,801) | 1,178 | ||||
EBITDAC | $267,862 | $201,914 | $426,993 | $308,420 | ||||
Acquisition-related expense | 15,183 | 16,168 | 32,485 | 24,605 | ||||
Acquisition related long-term incentive compensation | 9,321 | 2,891 | 17,652 | 1,264 | ||||
Restructuring and related expense | — | 7,968 | — | 37,006 | ||||
Amortization and expense related to discontinued prepaid incentives | 1,128 | 1,344 | 2,306 | 2,756 | ||||
Other non-operating loss (income) | 143 | 233 | (234) | 1,985 | ||||
Equity-based compensation | 14,853 | 12,756 | 29,422 | 22,271 | ||||
IPO related expenses | 5,072 | 8,139 | 10,376 | 15,934 | ||||
(Income) from equity method investments | (5,156) | (3,722) | (10,093) | (9,328) | ||||
Adjusted EBITDAC | $308,406 | $247,691 | $508,907 | $404,913 | ||||
Net income margin | 14.6 % | 17.0 % | 7.8 % | 12.7 % | ||||
Adjusted EBITDAC margin | 36.1 % | 35.6 % | 32.9 % | 32.5 % |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
(in thousands, except percentages) | 2025 | 2024 | 2025 | 2024 | ||||
Total revenue | $855,170 | $695,441 | $1,545,336 | $1,247,487 | ||||
Net income | $124,705 | $118,038 | $120,316 | $158,715 | ||||
Income tax expense | 13,026 | 18,691 | 68,456 | 25,117 | ||||
Amortization | 69,668 | 30,541 | 134,653 | 58,529 | ||||
Amortization of deferred debt issuance costs (1) | 2,386 | 3,027 | 4,760 | 6,436 | ||||
Change in contingent consideration | (759) | 1,243 | (14,801) | 1,178 | ||||
Acquisition-related expense | 15,183 | 16,168 | 32,485 | 24,605 | ||||
Acquisition related long-term incentive compensation | 9,321 | 2,891 | 17,652 | 1,264 | ||||
Restructuring and related expense | — | 7,968 | — | 37,006 | ||||
Amortization and expense related to discontinued prepaid incentives | 1,128 | 1,344 | 2,306 | 2,756 | ||||
Other non-operating loss (income) | 143 | 233 | (234) | 1,985 | ||||
Equity-based compensation | 14,853 | 12,756 | 29,422 | 22,271 | ||||
IPO related expenses | 5,072 | 8,139 | 10,376 | 15,934 | ||||
(Income) from equity method investments | (5,156) | (3,722) | (10,093) | (9,328) | ||||
Adjusted income before income taxes (2) | $249,570 | $217,317 | $395,298 | $346,468 | ||||
Adjusted income tax expense (3) | (64,888) | (56,763) | (102,777) | (90,497) | ||||
Adjusted net income | $184,682 | $160,554 | $292,521 | $255,971 | ||||
Net income margin | 14.6 % | 17.0 % | 7.8 % | 12.7 % | ||||
Adjusted net income margin | 21.6 % | 23.1 % | 18.9 % | 20.5 % |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Earnings per share of Class A common stock – diluted | $0.38 | $0.37 | $0.18 | $0.49 | ||||
Less: Net income attributed to dilutive shares and substantively vested RSUs (1) | (0.19) | (0.20) | — | (0.26) | ||||
Plus: Impact of all LLC Common Units exchanged for Class A shares (2) | 0.26 | 0.27 | 0.26 | 0.36 | ||||
Plus: Adjustments to Adjusted net income (3) | 0.22 | 0.15 | 0.63 | 0.36 | ||||
Plus: Dilutive impact of unvested equity awards (4) | (0.01) | (0.01) | (0.02) | (0.02) | ||||
Adjusted diluted earnings per share | $0.66 | $0.58 | $1.05 | $0.93 | ||||
(Share count in ’000) | ||||||||
Weighted-average shares of Class A common stock outstanding – diluted | 274,145 | 271,219 | 138,167 | 270,570 | ||||
Plus: Impact of all LLC Common Units exchanged for Class A shares (2) | — | — | 135,804 | — | ||||
Plus: Dilutive impact of unvested equity awards (4) | 5,275 | 4,446 | 5,422 | 4,821 | ||||
Adjusted diluted earnings per share diluted share count | 279,420 | 275,665 | 279,393 | 275,391 |
(in thousands) | Exchange Tax Attributes | Pre-IPO M&A Tax Attributes | TRA Payment Tax Attributes | TRA Liabilities | ||||
Balance at December 31, 2024 | $253,233 | $83,415 | $99,648 | $436,296 | ||||
Exchange of LLC Common Units | 17,861 | 1,176 | 5,423 | 24,460 | ||||
Accrued interest | — | — | 356 | 356 | ||||
Balance at June 30, 2025 | $271,094 | $84,591 | $105,427 | $461,112 |
Long-term Incentive Compensation Agreements | ||
(in thousands) | June 30, 2025 | |
Current accrued compensation | $7,049 | |
Non-current accrued compensation | 25,319 | |
Total liability | $32,368 | |
Projected future expense | 35,510 | |
Total projected future cash outflows | $67,878 |
Projected Future Cash Outflows | ||
(in thousands) | ||
2025 | $6,126 | |
2026 | 10,301 | |
2027 | 12,979 | |
2028 | 35,591 | |
Thereafter | $2,882 |
Contingent Consideration | ||
(in thousands) | June 30, 2025 | |
Current accounts payable and accrued liabilities | $22,703 | |
Other non-current liabilities | 91,924 | |
Total liability | $114,627 | |
Projected future expense | 13,842 | |
Total projected future cash outflows | $128,469 |
Projected Future Cash Outflows | ||
(in thousands) | ||
2025 | $268 | |
2026 | 35,988 | |
2027 | 80,364 | |
2028 | 5,896 | |
Thereafter | $5,954 |
(in thousands) | Balance at June 30, 2025 | 100 BPS Increase | 100 BPS Decrease | |||
Cash and cash equivalents | $172,589 | $(1,726) | $1,726 | |||
Term Loan principal outstanding (1) | 1,691,500 | 16,915 | (16,915) | |||
Interest rate cap notional amount (2) | 1,000,000 | (10,000) | 10,000 | |||
Net exposure to Interest expense, net | $5,189 | $(5,189) | ||||
Cash and cash equivalents held in a fiduciary capacity | $1,346,173 | $13,462 | $(13,462) | |||
Net exposure to Fiduciary investment income | $13,462 | $(13,462) | ||||
Impact to Net income | $8,273 | $(8,273) |
Exhibit Number | Description | |
3.1 | Amended and Restated Certificate of Incorporation of Ryan Specialty Holdings, Inc., dated May 30, 2025 (incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K filed on June 4, 2025). | |
3.2 | Amended and Restated Bylaws of Ryan Specialty Holdings, Inc., dated May 30, 2025 (incorporated by reference to Exhibit 3.2 to the Registrant’s Form 8-K filed on June 4, 2025). | |
4.1 | Registration Rights Agreement, dated July 26, 2021, by and among Ryan Specialty Holdings, Inc., and the other signatories party thereto (incorporated by reference to Exhibit 4.1 to the Registrant’s Form 8-K filed on July 27, 2021). | |
4.2 | Indenture, dated as of February 3, 2022, by and among Ryan Specialty, LLC, the guarantors party thereto and U.S. Bank National Association as trustee and as notes collateral agent (incorporated by reference to Exhibit 4.1 to the Registrant’s Form 8-K filed on February 7, 2022). | |
4.3 | Form of 4.375% Senior Secured Notes due 2030 (incorporated by reference to Exhibit A to Exhibit 4.1 to the Registrant’s Form 8-K filed on February 7, 2022). | |
4.4 | Indenture, dated as of September 19, 2024, by and among Ryan Specialty, LLC, the guarantors party thereto and U.S. Bank National Association as trustee and as notes collateral agent (incorporated by reference to Exhibit 4.1 to the Registrant’s Form 8-K filed on September 19, 2024). | |
4.5 | Form of 5.875% Senior Secured Notes due 2032 (incorporated by reference to Exhibit A to Exhibit 4.1 to the Registrant’s Form 8-K filed on September 19, 2024). | |
4.6 | First Supplemental Indenture to that certain Indenture, dated as of September 19, 2024, by and among Ryan Specialty, LLC, the guarantors party thereto and U.S. Bank National Association as trustee and as notes collateral agent (incorporated by reference to Exhibit 4.2 to the Registrant’s Form 8-K filed on December 9, 2024) | |
10.1 | Amended and Restated Tax Receivable Agreement, dated as of August 9, 2022, by and among Ryan Specialty Holdings, Inc., and the other signatories party thereto (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed on August 12, 2022). | |
10.2 | Eighth Amended and Restated Limited Liability Company Agreement of Ryan Specialty, LLC, dated as of July 5, 2023, by and among Ryan Specialty, LLC, and the other signatories party thereto, (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q filed on November 03, 2023). | |
10.3 | Form of Director and Officer Indemnification Agreement, by and among Ryan Specialty Holdings, Inc., and the other signatories party thereto (incorporated by reference to Exhibit 10.4 to the Registrant’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on June 21, 2021). | |
10.4 | Indemnification Agreement, by and among Ryan Specialty Holdings, Inc., and Patrick G. Ryan, dated as of July 26, 2021 (incorporated by reference to Exhibit 10.4 to the Registrant’s Form 8-K filed on July 27, 2021). | |
10.5 | Director Nomination Agreement, dated as of July 26, 2021, by and among Ryan Specialty Holdings, Inc., and the other signatories party thereto (incorporated by reference to Exhibit 10.5 to the Registrant’s Form 8- K filed on July 27, 2021). | |
10.6 | Ryan Specialty Holdings, Inc. 2021 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.7 to the Registrant’s Quarterly Report on Form 10-Q filed on August 12, 2022). | |
10.7 | First Amendment to the Ryan Specialty Holdings, Inc. 2021 Omnibus Incentive Plan, (incorporated by reference to Exhibit 10.8 to the Registrant’s Form 10-K filed on March 1, 2023). | |
10.8 | Ryan Specialty Holdings, Inc. Form of Class C Common Incentive Unit Grant Agreement (Staking Unit) (incorporated by reference to Exhibit 10.6 to the Registrant’s Registration Statement on Form S-8 filed on July 23, 2021). | |
10.9 | Ryan Specialty Holdings, Inc. Form of Class C Common Incentive Unit Grant Agreement (Reload Unit) (incorporated by reference to Exhibit 10.7 to the Registrant’s Registration Statement on Form S-8 filed on July 23, 2021). | |
10.10 | Ryan Specialty Holdings, Inc. Form of Common Unit Grant Agreement (incorporated by reference to Exhibit 10.8 to the Registrant’s Registration Statement on Form S-8 filed on July 23, 2021). | |
10.11 | Ryan Specialty Holdings, Inc., Form of Restricted Stock Unit Agreement (Non-Employee Directors) (incorporated by reference to Exhibit 10.15 to the Registrant’s Form 10-K filed on March 16, 2022). | |
10.12 | Ryan Specialty Holdings, Inc. Form of Restricted LLC Unit Agreement (2022), (incorporated by reference to Exhibit 10.11 to the Registrant’s Form 10-K filed on February 28, 2024). | |
10.13 | Ryan Specialty Holdings, Inc. Form of Class C Common Incentive Unit Grant Agreement (PSI Units), (incorporated by reference to Exhibit 10.12 to the Registrant’s Form 10-K filed on February 28, 2024). | |
10.14 | Ryan Specialty Holdings, Inc. Form of Performance-Based Restricted Stock Unit Agreement (DELTA PSUs), (incorporated by reference to Exhibit 10.14 to the Registrant’s Form 10-Q filed on May 30, 2024). | |
10.15 | Ryan Specialty Holdings, Inc. Form of Performance-Based Restricted LLC Unit Agreement (DELTA PLUs), (incorporated by reference to Exhibit 10.15 to the Registrant’s Form 10-K filed on February 28, 2024). | |
10.16 | Seventh Amendment to the Credit Agreement, dated September 13, 2024, including Exhibit A, a conformed copy of the Credit Agreement, dated as of September 1, 2020, among Ryan Specialty, LLC and JPMorgan Chase Bank, N.A., as administrative agent and the other lenders party thereto, as amended March 30, 2021, July 26, 2021, August 13, 2021, April 29, 2022, January 19, 2024, July 30, 2024 and September 13, 2024, (incorporated by reference to Exhibit 10.16 to the Registrant’s Form 10-Q filed on October 31, 2024). | |
10.17 | Third Amended and Restated Limited Liability Company Operating Agreement of New Ryan Specialty, LLC, dated as of July 5, 2023, by and among New Ryan Specialty, LLC, and the other signatories party thereto, (incorporated by reference to Exhibit 10.20 to the Registrant’s Quarterly Report on Form 10-Q filed on November 03, 2023). | |
10.18 | First Amendment to the Third Amended and Restated Limited Liability Company Operating Agreement of New Ryan Specialty, LLC, dated as of April 30, 2024, by and among New Ryan Specialty, LLC, and the other signatories party thereto, (incorporated by reference to Exhibit 10.18 to the Registrant’s Quarterly Report on Form 10-Q filed on August 02, 2024). | |
10.19 | Ryan Specialty Group Services, LLC Executive Severance Plan, (incorporated by reference to Exhibit 10.15 to the Registrant’s Form 10-K filed on February 28, 2024). | |
19.1 | Ryan Specialty Holdings, Inc. Insider Trading Policy dated May 1, 2023, (incorporated by reference to Exhibit 19.1 to the Registrant’s Form 10-K filed on February 21, 2025). | |
31.1 | Certification of the Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith. | |
31.2 | Certification of the Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith. | |
32.1* | Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, filed herewith. | |
32.2* | Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, filed herewith. | |
97.1 | Clawback Policy Pursuant to Rule 10D-1 under the Exchange Act, (incorporated by reference to Exhibit 97.1 to the Registrant’s Form 10-K filed on February 28, 2024). | |
101.INS | Inline XBRL (Extensible Business Reporting Language) Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |
101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | |
104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
RYAN SPECIALTY HOLDINGS, INC. (Registrant) | ||
Date: July 31, 2025 | By: | /s/ Janice M. Hamilton |
Janice M. Hamilton | ||
Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |